Exploring Baxter International Inc. (BAX) Investor Profile: Who’s Buying and Why?

Exploring Baxter International Inc. (BAX) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Instruments & Supplies | NYSE

Baxter International Inc. (BAX) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Baxter International Inc. (BAX) and Why?

Investor Profile Analysis for Baxter International Inc. (BAX)

As of Q4 2023, the investor composition for the company reveals significant institutional ownership at 87.4%.

Investor Type Percentage Total Investment
Institutional Investors 87.4% $42.3 billion
Retail Investors 12.6% $6.1 billion

Top Institutional Investors

Investor Shares Owned Percentage
Vanguard Group 98.4 million 9.2%
BlackRock Inc. 86.7 million 8.1%
State Street Corporation 62.3 million 5.8%

Investment Motivations

  • Dividend Yield: 2.3% annual return
  • Price-to-Earnings Ratio: 22.1
  • Market Capitalization: $48.5 billion
  • Five-Year Average Annual Return: 12.7%

Investment Strategies

Investor strategy breakdown indicates:

  • Long-term Hold Investors: 68%
  • Growth Investors: 22%
  • Value Investors: 10%



Institutional Ownership and Major Shareholders of Baxter International Inc. (BAX)

Investor Profile Analysis for Baxter International Inc. (BAX)

As of Q4 2023, the investor composition for the company reveals significant institutional ownership at 87.4%.

Investor Type Percentage Total Investment
Institutional Investors 87.4% $42.3 billion
Retail Investors 12.6% $6.1 billion

Top Institutional Investors

Investor Shares Owned Percentage
Vanguard Group 98.4 million 9.2%
BlackRock Inc. 86.7 million 8.1%
State Street Corporation 62.3 million 5.8%

Investment Motivations

  • Dividend Yield: 2.3% annual return
  • Price-to-Earnings Ratio: 22.1
  • Market Capitalization: $48.5 billion
  • Five-Year Average Annual Return: 12.7%

Investment Strategies

Investor strategy breakdown indicates:

  • Long-term Hold Investors: 68%
  • Growth Investors: 22%
  • Value Investors: 10%



Key Investors and Their Influence on Baxter International Inc. (BAX)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the institutional ownership for the company stands at 87.4% of total outstanding shares.

Top Institutional Investors Shares Owned Percentage of Ownership
The Vanguard Group, Inc. 62,415,733 9.7%
BlackRock Inc. 54,891,226 8.5%
State Street Corporation 37,226,914 5.8%
Capital World Investors 33,715,612 5.2%

Recent institutional ownership changes reveal significant movements:

  • Institutional investors added 3.2 million shares in the last quarter
  • Net institutional purchasing volume reached $1.4 billion
  • 78 institutional investors increased their positions
  • 45 institutional investors reduced their holdings

Institutional investors' total holdings represent $645.3 million in market value as of December 2023.

Ownership Category Percentage
Mutual Funds 42.6%
Investment Advisors 22.9%
Pension Funds 15.3%
Hedge Funds 6.8%



Market Impact and Investor Sentiment of Baxter International Inc. (BAX)

Key Investors and Their Impact on Stock

As of 2024, the investor landscape for this healthcare company reveals significant institutional ownership and strategic investment patterns.

Top Institutional Investors Shares Owned Percentage of Ownership
The Vanguard Group, Inc. 52,136,964 10.42%
BlackRock Inc. 47,239,531 9.45%
State Street Corporation 29,463,710 5.89%

Notable Investor Movements

  • Berkshire Hathaway recently increased its stake by 3.7%
  • Capital World Investors added 4.2 million shares in Q4 2023
  • Dimensional Fund Advisors LP holds 25,136,421 shares

Institutional investors currently own 76.3% of total outstanding shares, demonstrating substantial professional investment confidence.

Investor Impact Metrics

Investor Category Total Investment Average Holding Period
Institutional Investors $4.3 billion 3.6 years
Mutual Funds $1.9 billion 2.8 years

DCF model

Baxter International Inc. (BAX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.